Raffa Wealth Management’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$132 Buy
+2
New +$153 ﹤0.01% 1334

Other funds holding CYTK

Raffa Wealth Management's CYTK Position: Q3 2026 in Review

Raffa Wealth Management opened a new position in Cytokinetics (CYTK) in Q3 2026: 2 shares worth $132. The stake represents ﹤0.01% of the portfolio and ranks #1334 among its holdings.

473 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.

  • Raffa Wealth Management held 2 shares of Cytokinetics worth $132 as of Q3 2026.
  • Cytokinetics was a new Raffa Wealth Management position in Q3 2026.
  • Cytokinetics made up ﹤0.01% of Raffa Wealth Management's portfolio in Q3 2026, its #1334 holding.
  • 473 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.

Based on Raffa Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.